The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Osteopontin in Bone Metabolism and Bone Diseases
Open accessAbstract
Osteopontin (OPN), a secreted phosphoprotein, is a member of the small integrin-binding ligand N-linked glycoprotein (SIBLING) family of cell matrix proteins and participates in many biological activities. Studies have shown that OPN plays a role in bone metabolism and homeostasis. OPN not only is an important factor in neuron-mediated and endocrine-regulated bone mass, but also is involved in biological activities such as proliferation, migration, and adhesion of several bone-related cells, including bone marrow mesenchymal stem cells, hematopoietic stem cells, osteoclasts, and osteoblasts. OPN has been demonstrated to be closely related to the occurrence and development of many bone-related diseases, such as osteoporosis, rheumatoid arthritis, and osteosarcoma. As expected, the functions of OPN in the bone have become a research hotspot. In this article, we try to decipher the mechanism of OPN-regulated bone metabolism and bone diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoporosis: now and the future
Rachner, T. D., Khosla, S., & Hofbauer, L. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62349-5 · Cited by 2,696
Compston, J. E., McClung, M. R., & Leslie, W. D. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32112-3 · Cited by 2,449
Oldberg, A., Franzén, A., & Heinegård, D. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.8819 · Cited by 1,078
CD44: Structure, Function and Association with the Malignant Process
(1997) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60101-3 · Cited by 1,016
Nilsson, S. K., Johnston, H. M., Whitty, G. A., Williams, B., Webb, R. J., Denhardt, D. T., Bertoncello, I., Bendall, L. J., Simmons, P. J., & Haylock, D. N. (2005) · Blood · doi:10.1182/blood-2004-11-4422 · Cited by 806
Giachelli, C. M., Bae, N., Almeida, M., Denhardt, D. T., Alpers, C. E., & Schwartz, S. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116755 · Cited by 641
Osteopontin: a versatile regulator of inflammation and biomineralization
Giachelli, C. M., & Steitz, S. (2000) · Matrix Biology · doi:10.1016/s0945-053x(00)00108-6 · Cited by 583
Liaw, L., Skinner, M. P., Raines, E. W., Ross, R., Cheresh, D. A., Schwartz, S. M., & Giachelli, C. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117718 · Cited by 512
Calcification of Vascular Smooth Muscle Cell Cultures: Inhibition by Osteopontin
Wada, T., McKee, M. D., Steitz, S., & Giachelli, C. M. (1999) · Circulation Research · doi:10.1161/01.res.84.2.166 · Cited by 458
Osteopontin Is Expressed in Human Aortic Valvular Lesions
O’Brien, K. D., Kuusisto, J., Reichenbach, D. D., Ferguson, M., Giachelli, C., Alpers, C. E., & Otto, C. M. (1995) · Circulation · doi:10.1161/01.cir.92.8.2163 · Cited by 440
Hunter, G. K., Kyle, C. L., & Goldberg, H. A. (1994) · Biochemical Journal · doi:10.1042/bj3000723 · Cited by 432
Boskey, A. L., Maresca, M., Ullrich, W., Doty, S. B., Butler, W. T., & Prince, C. W. (1993) · Bone and Mineral · doi:10.1016/s0169-6009(08)80225-5 · Cited by 429
Osteopontin Inhibits Mineral Deposition and Promotes Regression of Ectopic Calcification
Steitz, S. A., Speer, M. Y., McKee, M. D., Liaw, L., Almeida, M., Yang, H., & Giachelli, C. M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64482-3 · Cited by 422
Addison, W. N., Azari, F., Sørensen, E. S., Kaartinen, M. T., & McKee, M. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701116200 · Cited by 403
Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption
Yoshitake, H., Rittling, S. R., Denhardt, D. T., & Noda, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8156 · Cited by 374
An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion
Klement, J. D., Paschall, A. V., Redd, P. S., Ibrahim, M. L., Lu, C., Yang, D., Celis, E., Abrams, S. I., Ozato, K., & Liu, K. (2018) · Journal of Clinical Investigation · doi:10.1172/jci123360 · Cited by 368
Osteosarcoma Development and Stem Cell Differentiation
Tang, N., Song, W.-X., Luo, J., Haydon, R. C., & He, T.-C. (2008) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-008-0335-z · Cited by 357
Immunohistochemical Localization of Klotho Protein in Brain, Kidney, and Reproductive Organs of Mice
Li, S.-A., Watanabe, M., Yamada, H., Nagai, A., Kinuta, M., & Takei, K. (2004) · Cell Structure and Function · doi:10.1247/csf.29.91 · Cited by 351
Role of Osteopontin in Cellular Signaling and Toxicant Injury
Denhardt, D. T., Giachelli, C. M., & Rittling, S. R. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.723 · Cited by 349
Jono, S., Peinado, C., & Giachelli, C. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909174199 · Cited by 339
Speer, M. Y., McKee, M. D., Guldberg, R. E., Liaw, L., Yang, H.-Y., Tung, E., Karsenty, G., & Giachelli, C. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020911 · Cited by 334
Phosphate-Induced Vascular Calcification: Role of Pyrophosphate and Osteopontin
Lomashvili, K. A., Cobbs, S., Hennigar, R. A., Hardcastle, K. I., & O’Neill, W. C. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000128955.83129.9c · Cited by 320
A biomechanical perspective on bone quality
Hernandez, C. J., & Keaveny, T. M. (2006) · Bone · doi:10.1016/j.bone.2006.06.001 · Cited by 319
Importance of Phosphorylation for Osteopontin Regulation of Biomineralization
Gericke, A., Qin, C., Spevak, L., Fujimoto, Y., Butler, W. T., Sørensen, E. S., & Boskey, A. L. (2005) · Calcified Tissue International · doi:10.1007/s00223-004-1288-1 · Cited by 315
The balance of Th1/Th2 cytokines in rheumatoid arthritis
Schulze-Koops, H., & Kalden, J. R. (2001) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2001.0187 · Cited by 275
A Biochemical Characterization of the Binding of Osteopontin to Integrins αvβ1 and αvβ5
Hu, D. D., Lin, E. C. K., Kovach, N. L., Hoyer, J. R., & Smith, J. W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26232 · Cited by 254
Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice.
Bourassa, P. A., Milos, P. M., Gaynor, B. J., Breslow, J. L., & Aiello, R. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10022 · Cited by 253
Chen, Q., Shou, P., Zhang, L., Xu, C., Zheng, C., Han, Y., Li, W., Huang, Y., Zhang, X., Shao, C., et al. (2014) · Stem Cells · doi:10.1002/stem.1567 · Cited by 248
PGC1β Mediates PPARγ Activation of Osteoclastogenesis and Rosiglitazone-Induced Bone Loss
Wei, W., Wang, X., Yang, M., Smith, L. C., Dechow, P. C., & Wan, Y. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.04.015 · Cited by 243
Chen, Y., Bal, B. S., & Gorski, J. P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35844-7 · Cited by 233
Regulation of bone remodeling by the central and peripheral nervous system
Elefteriou, F. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.03.016 · Cited by 229 · cited 1×
“The sympathetic nervous system regulates bone mass by changing local bone remodeling through b2-adrenergic receptor (b2AR) [18].”
BackgroundOsako, M. K., Nakagami, H., Koibuchi, N., Shimizu, H., Nakagami, F., Koriyama, H., Shimamura, M., Miyake, T., Rakugi, H., & Morishita, R. (2010) · Circulation Research · doi:10.1161/circresaha.110.216846 · Cited by 220
Mark, M. P., Butler, W. T., Prince, C. W., Finkelman, R. D., & Ruch, J.-V. (1988) · Differentiation · doi:10.1111/j.1432-0436.1988.tb00804.x · Cited by 216
Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects
Luo, X., Chen, J., Song, W.-X., Tang, N., Luo, J., Deng, Z.-L., Sharff, K. A., He, G., Bi, Y., He, B.-C., et al. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.98 · Cited by 216
Osteopontin is a ligand for the α4β1 integrin
Bayless, K. J., Meininger, G. A., Scholtz, J. M., & Davis, G. E. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.9.1165 · Cited by 214
Osteopontin: An Interfacial Extracellular Matrix Protein in Mineralized Tissues
Mckee, M. D., & Nanci, A. (1996) · Connective Tissue Research · doi:10.3109/03008209609029192 · Cited by 202
Consensus development conference: Prophylaxis and treatment of osteoporosis
(1991) · Osteoporosis International · doi:10.1007/bf01880454 · Cited by 197
The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease
Kiechl, S., Werner, P., Knoflach, M., Furtner, M., Willeit, J., & Schett, G. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.4.6.801 · Cited by 195
Osteopontin deficiency increases bone fragility but preserves bone mass
Thurner, P. J., Chen, C. G., Ionova-Martin, S., Sun, L., Harman, A., Porter, A., Ager, J. W., Ritchie, R. O., & Alliston, T. (2010) · Bone · doi:10.1016/j.bone.2010.02.014 · Cited by 190
Immunohistochemical demonstration of a 44-KD phosphoprotein in developing rat bones.
Mark, M. P., Prince, C. W., Oosawa, T., Gay, S., Bronckers, A. L., & Butler, W. T. (1987) · Journal of Histochemistry & Cytochemistry · doi:10.1177/35.7.3295029 · Cited by 187
Cañete, J. D., Martínez, S. E., Farrés, J., Sanmartí, R., Blay, M., Gómez, A., Salvador, G., & Muñoz-Gómez, J. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.4.263 · Cited by 183
Osteopontin attenuates aging‐associated phenotypes of hematopoietic stem cells
Guidi, N., Sacma, M., Ständker, L., Soller, K., Marka, G., Eiwen, K., Weiss, J. M., Kirchhoff, F., Weil, T., Cancelas, J. A., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201694969 · Cited by 173
Lee, M. N., Hwang, H.-S., Oh, S., Roshanzadeh, A., Kim, J.-W., Song, J. H., Kim, E., & Koh, J. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0170-6 · Cited by 171
Integrins and bone metastasis: Integrating tumor cell and stromal cell interactions
Schneider, J. G., Amend, S. R., & Weilbaecher, K. N. (2011) · Bone · doi:10.1016/j.bone.2010.09.016 · Cited by 169
Notch signaling contributes to the pathogenesis of human osteosarcomas
Engin, F., Bertin, T., Ma, O., Jiang, M. M., Wang, L., Sutton, R. E., Donehower, L. A., & Lee, B. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp057 · Cited by 168
Microcalcifications in breast cancer: From pathophysiology to diagnosis and prognosis
O’Grady, S., & Morgan, M. P. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.04.006 · Cited by 167
Yokosaki, Y., Tanaka, K., Higashikawa, F., Yamashita, K., & Eboshida, A. (2005) · Matrix Biology · doi:10.1016/j.matbio.2005.05.005 · Cited by 165
Cox, R. F., Hernández-Santana, A., Ramdass, S. K., McMahon, G. P., Harmey, J. H., & Morgan, M. P. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.583 · Cited by 163
The Integrin {alpha} v {beta} 3 and CD44 Regulate the Actions of Osteopontin on Osteoclast Motility
Chellaiah, M. A., & Hruska, K. A. (2003) · Calcified Tissue International · doi:10.1007/s00223-002-1025-6 · Cited by 157
The role of RANK ligand/osteoprotegerin in rheumatoid arthritis
Geusens, P. (2012) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x12438080 · Cited by 153
Osteopontin: a bridge between bone and blood
Haylock, D. N., & Nilsson, S. K. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06218.x · Cited by 150
Mackie, P. S., Fisher, J. L., Zhou, H., & Choong, P. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1679 · Cited by 149
Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts
Honorati, M. C., Neri, S., Cattini, L., & Facchini, A. (2005) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2005.10.004 · Cited by 137
Klotho expression in osteocytes regulates bone metabolism and controls bone formation
Komaba, H., Kaludjerovic, J., Hu, D. Z., Nagano, K., Amano, K., Ide, N., Sato, T., Densmore, M., Hanai, J.-I., Olauson, H., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.02.014 · Cited by 134
Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers
Kruger, T. E., Miller, A. H., Godwin, A. K., & Wang, J. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.08.013 · Cited by 132
Parathyroid Hormone-induced Bone Resorption Does Not Occur in the Absence of Osteopontin
Ihara, H., Denhardt, D. T., Furuya, K., Yamashita, T., Muguruma, Y., Tsuji, K., Hruska, K. A., Higashio, K., ENOMOTO, S., Nifuji, A., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010938200 · Cited by 125
Osteopontin—A Master Regulator of Epithelial-Mesenchymal Transition
Kothari, A. N., Arffa, M., Chang, V. A., Blackwell, R. H., Syn, W., Zhang, J., Mi, Z., & Kuo, P. C. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5040039 · Cited by 121
Huang, W., Carlsen, B. T., Rudkin, G. H., Berry, M. D., Ishida, K., Yamaguchi, D. T., & Miller, T. A. (2004) · Bone · doi:10.1016/j.bone.2003.11.027 · Cited by 118
Denhardt, D., Mistretta, D., Chambers, A., Krishna, S., Porter, J., Raghuram, S., & Rittling, S. (2004) · Clinical and Experimental Metastasis · doi:10.1023/a:1022550721404 · Cited by 115
Epigallocatechin-3-gallate (EGCG) enhances the therapeutic activity of a dental adhesive
Du, X., Huang, X., Huang, C., Wang, Y., & Zhang, Y. (2012) · Journal of Dentistry · doi:10.1016/j.jdent.2012.02.013 · Cited by 112
Zou, C., Luo, Q., Qin, J., Shi, Y., Yang, L., Ju, B., & Song, G. (2012) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-012-9449-8 · Cited by 106
Structural Requirements for α9β1-Mediated Adhesion and Migration to Thrombin-Cleaved Osteopontin
Smith, L. L., & Giachelli, C. M. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4108 · Cited by 105
Chatakun, P., Núñez-Toldrà, R., López, E. J. D., Gil-Recio, C., Martínez‐Sarrà, E., Hernández-Alfaro, F. J., Ferrés‐Padró, E., Giner, L., & Atari, M. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1326-0 · Cited by 105
Mutations in the LMNA gene encoding lamin A/C
Büttner, J., & Schmidt, H. (2000) · Human Mutation · Cited by 104
FGF23-αKlotho as a paradigm for a kidney-bone network
Kuro‐o, M., & Moe, O. W. (2016) · Bone · doi:10.1016/j.bone.2016.11.013 · Cited by 102
Structural elements of the osteopontin SVVYGLR motif important for the interaction with α4 integrins
Green, P. M., Ludbrook, S. B., Miller, D. D., Horgan, C. M. T., & Barry, S. T. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02690-4 · Cited by 101
Sympathetic control of bone mass regulated by osteopontin
Nagao, M., Feinstein, T. N., Ezura, Y., Hayata, T., Notomi, T., Saita, Y., Hanyu, R., Hemmi, H., Izu, Y., Takeda, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109402108 · Cited by 101
Increased serum osteopontin is a risk factor for osteoporosis in menopausal women
Chang, I.-C., Chiang, T.-I., Yeh, K.-T., et al. (2010) · Osteoporosis International · doi:10.1007/s00198-009-1107-7 · Cited by 94
Mountzios, G., Dimopoulos, M. A., Bamias, A., Papadopoulos, G., Kastritis, E., Syrigos, K., Pavlakis, G., & Terpos, E. (2006) · Acta Oncologica · doi:10.1080/02841860600635870 · Cited by 86
Bellahcène, A., & CASTRONOVO, V. (1997) · PubMed · Cited by 85
Regulatory Mechanisms of RANKL Presentation to Osteoclast Precursors
Honma, M., Ikebuchi, Y., Kariya, Y., & Suzuki, H. (2014) · Current Osteoporosis Reports · doi:10.1007/s11914-014-0189-0 · Cited by 80
A Regulated Interaction between α5β1 Integrin and Osteopontin
Barry, S. T., Ludbrook, S. B., Murrison, E., & Horgan, C. M. T. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.2032 · Cited by 80
Breyne, J., Juthier, F., Corseaux, D., Maréchaux, S., Zawadzki, C., Jeanpierre, E., Ung, A., Ennezat, P., Susen, S., BELLE, E. V., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.07.047 · Cited by 78
MicroRNA-Based Diagnosis and Treatment of Metastatic Human Osteosarcoma
Sasaki, R., Osaki, M., & Okada, F. (2019) · Cancers · doi:10.3390/cancers11040553 · Cited by 66
Bonnelye, E., Kung, V., Laplace, C., Galson, D. L., & Aubin, J. E. (2002) · Endocrinology · doi:10.1210/en.2002-220095 · Cited by 62
The Value of Osteopontin in the Assessment of Bone Mineral Density Status in Postmenopausal Women
Fodor, D., Bondor, C. I., Albu, A., Simon, S.-P., Craciun, A. M., & Muntean, L. M. (2013) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3182761264 · Cited by 60
Sun, Y., Yao, Y., & Ding, C. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.11.014 · Cited by 60
Osteopontin Signals through Calcium and Nuclear Factor of Activated T Cells (NFAT) in Osteoclasts
Tanabe, N., Wheal, B. D., Kwon, J., Chen, H. H., Shugg, R. P. P., Sims, S. M., Goldberg, H. A., & Dixon, S. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.295048 · Cited by 53
Zirngibl, R. A., Chan, J. S. M., & Aubin, J. E. (2007) · Journal of Molecular Endocrinology · doi:10.1677/jme-07-0114 · Cited by 51
Poggio, P., Grau, J. B., Field, B. C., Sainger, R., Seefried, W. F., Rizzolio, F., & Ferrari, G. M. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22549 · Cited by 50
The value of biomarkers in bone metastasis
D’Oronzo, S., Brown, J. E., & Coleman, R. E. (2017) · European Journal of Cancer Care · doi:10.1111/ecc.12725 · Cited by 50
Erratum To: Osteopontin attenuates aging‐associated phenotypes of hematopoietic stem cells
Guidi, N., Saçma, M., Ständker, L., Soller, K., Marka, G., Eiwen, K., Weiss, J. M., Kirchhoff, F., Weil, T., Cancelas, J. A., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201796968 · Cited by 49
ERR receptors as potential targets in osteoporosis
Gallet, M., & Vanacker, J.-M. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.06.008 · Cited by 46
Walker, C. G., Dangaria, S. J., Ito, Y., Luan, X., & Diekwisch, T. G. H. (2010) · Bone · doi:10.1016/j.bone.2010.08.025 · Cited by 46
Assessing the Feasibility of Neutralizing Osteopontin with Various Therapeutic Antibody Modalities
Farrokhi, V., Chabot, J., Neubert, H., & Yang, Z. (2018) · Scientific Reports · doi:10.1038/s41598-018-26187-w · Cited by 46
Forsprecher, J., Wang, Z., Goldberg, H. A., & Kaartinen, M. T. (2011) · Cell Adhesion & Migration · doi:10.4161/cam.5.1.13369 · Cited by 45
Kusuyama, J., Bandow, K., Ohnishi, T., Hisadome, M., Shima, K., Semba, I., & Matsuguchi, T. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-10-0716 · Cited by 45
Tsai, C., Liu, S., Wang, Y., Su, C., Huang, C., Hsu, C., & Tang, C. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.11.015 · Cited by 44
Qian, J., Xu, L., Sun, X., Wang, Y., Xuan, W., Zhang, Q., Zhao, P., Wu, Q., Liu, R., Che, N., et al. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1526-y · Cited by 44
Bernards, M. T., Qin, C., Ratner, B. D., & Jiang, S. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31650 · Cited by 43
Tanaka, S., Narusawa, K., Onishi, H., Miura, M., Hijioka, A., Kanazawa, Y., Nishida, S., Ikeda, S., & Nakamura, T. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1328-9 · Cited by 42
Mesenchymal stem cells require integrin β1 for directed migration induced by osteopontin in vitro
Zou, C., Song, G., Luo, Q., Yuan, L., & Yang, L. (2010) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-010-9377-0 · Cited by 41
Dual role of interleukin-17 in pannus growth and osteoclastogenesis in rheumatoid arthritis
Ito, H., Yamada, H., Shibata, T. N., Mitomi, H., Nomoto, S., & Ozaki, S. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3238 · Cited by 38
Studying biomineralization pathways in a 3D culture model of breast cancer microcalcifications
Vidavsky, N., Kunitake, J. A. M. R., Chiou, A. E., Northrup, P. A., Porri, T. J., Lu, L., Fischbach, C., & Estroff, L. A. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.06.030 · Cited by 38
Chiang, T.-I., Chang, I.-C., Lee, H.-S., Lee, H., Huang, C.-H., & Cheng, Y. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1327-x · Cited by 36
Bouleftour, W., Bouet, G., Granito, R. N., Thomas, M., Linossier, M., Vanden‐Bossche, A., Aubin, J. E., Lafage‐Proust, M., Vico, L., & Malaval, L. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24772 · Cited by 35
Jørgensen, L., Joakimsen, O., Mathiesen, E. B., Ahmed, L. A., Berntsen, G., Fønnebø, V. M., Joakimsen, R. M., Njølstad, I., Schirmer, H., & Jacobsen, B. K. (2006) · Calcified Tissue International · doi:10.1007/s00223-006-0071-x · Cited by 35
Polyoma Virus-Induced Osteosarcomas in Inbred Strains of Mice: Host Determinants of Metastasis
Velupillai, P., Sung, C. K., Tian, Y., Dahl, J., Carroll, J., Bronson, R. T., & Benjamin, T. L. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000733 · Cited by 32
Osteopontin Upregulates the Expression of Glucose Transporters in Osteosarcoma Cells
Hsieh, I., Yang, R., & Fu, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109550 · Cited by 27
Osteopontin Has a Crucial Role in Osteoclast‐Like Multinucleated Giant Cell Formation
Oh, Y., Oh, I., Morimoto, J. O., Uede, T., & Morimoto, A. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24695 · Cited by 27
Regulation of osteosarcoma cell invasion through osteopontin modification by miR-4262
Song, K., Liu, N., Yang, Y., & Qiu, X. (2015) · Tumor Biology · doi:10.1007/s13277-015-4530-8 · Cited by 27
Distinctive and selective route of PI3K/PKCα-PKCδ/RhoA-Rac1 signaling in osteoclastic cell migration
Kim, J., Kim, M. Y., Lee, K., & Jeong, D. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.042 · Cited by 27
Fra-2 Expression in Osteoblasts Regulates Systemic Inflammation and Lung Injury through Osteopontin
Luo, Y., Grötsch, B., Hannemann, N., Jiménez, M., Ipseiz, N., Uluçkan, Ö., Lin, N., Schett, G. A., Wagner, E. F., & Bözec, A. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00022-18 · Cited by 15
Selective regulation of osteoclast adhesion and spreading by PLCγ/PKCα-PKCδ/RhoA-Rac1 signaling
Kim, J., Lee, K., & Jeong, D. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.5.198 · Cited by 10
MicroRNAs for osteosarcoma in the mouse: a meta-analysis
Chang, J., Yao, M., Li, Y., Zhao, D., Hu, S., Cui, X., Liu, G., Shi, Q., Wang, Y., & Yang, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.13333 · Cited by 8
Morishita, M., Ono, N., Miyai, K., Nakagawa, T., Hanyu, R., Nagao, M., Kamolratanakul, P., Notomi, T., Rittling, S. R., Denhardt, D. T., et al. (2011) · Tissue and Cell · doi:10.1016/j.tice.2011.02.003 · Cited by 5
Cited by
Regulation of short-chain fatty acids in the immune system
Liu, X.-F., Shao, J.-H., Liao, Y.-T., Wang, L.-N., Jia, Y., Dong, P.-J., Liu, Z.-Z., He, D.-D., Li, C., & Zhang, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1186892 · Cited by 403
The Development of Molecular Biology of Osteoporosis
Gao, Y., Patil, S., & Jia, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158182 · Cited by 116
Role and Regulation of Transcription Factors in Osteoclastogenesis
Jiang, T., Xia, T., Qiao, F., Wang, N., Jiang, Y., & Xin, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216175 · Cited by 60
Bone-derived factors mediate crosstalk between skeletal and extra-skeletal organs
He, T., Qin, L., Chen, S., Huo, S., Li, J., Zhang, F., Yi, W., Mei, Y., & Xiao, G. (2025) · Bone Research · doi:10.1038/s41413-025-00424-1 · Cited by 58
Lin, W., Li, Y., Qiu, C., Zou, B., Gong, Y., Zhang, X., Tian, D., Sherman, W., Sanchez, F., Wu, D., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkae1298 · Cited by 46
Metadata
- Authors
- Si, J., Wang, C., Zhang, D., Wang, B., Hou, W., & Zhou, Y.
- Venue
- Medical Science Monitor
- Published
- 2020-01-17
- Volume
- 26
- Pages
- e919159-e919159
- ISSN
- 1234-1010 (ISSN-L)
- 1643-3750
- OpenAlex
- W3000580091
- Cited by
- 301
- References
- 106
- FWCI
- 21.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.